Improving Bacillus subtilis as Biological Chassis Performance by the CRISPR Genetic Toolkit
ACS Synthetic Biology,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 4, 2025
Bacillus
subtilis
is
the
model
Gram-positive
and
industrial
chassis
bacterium;
it
has
blossomed
as
a
robust
promising
host
for
enzyme,
biochemical,
or
bioflocculant
production.
However,
synthetic
biology
metabolic
engineering
technologies
of
B.
have
lagged
behind
most
widely
used
Saccharomyces
cerevisiae
Escherichia
coli.
CRISPR
(an
acronym
clustered
regularly
interspaced
short
palindromic
repeats)
enables
efficient,
site-specific,
programmable
DNA
cleavage,
which
revolutionized
manner
genome
editing.
In
2016,
technology
was
first
introduced
into
been
intensely
upgraded
since
then.
this
Review,
we
discuss
recently
developed
key
additions
to
toolkit
design
in
with
gene
editing,
transcriptional
regulation,
enzyme
modulation.
Second,
advances
efficient
biochemicals
proteins
are
discussed.
Finally,
conclude
perspectives
on
challenges
opportunities
CRISPR-based
biotechnology
subtilis,
wishing
that
can
be
comparable
traditional
microorganisms
such
E.
coli
S.
someday
soon.
Язык: Английский
Intelligent biomanufacturing of water-soluble vitamins
Trends in biotechnology,
Год журнала:
2025,
Номер
unknown
Опубликована: Май 1, 2025
Язык: Английский
CRISPR-Based Regulation for High-Throughput Screening
ACS Synthetic Biology,
Год журнала:
2025,
Номер
unknown
Опубликована: Май 22, 2025
CRISPR
technology
has
revolutionized
genome
editing
by
enabling
precise,
permanent
modifications
to
genetic
material.
To
circumvent
the
irreversible
alterations
associated
with
traditional
methods
and
facilitate
research
on
both
essential
nonessential
genes,
interference
or
inhibition
(CRISPRi)
activation
(CRISPRa)
were
developed.
The
gene-silencing
approach
leverages
an
inactivated
Cas
effector
protein
paired
guide
RNA
obstruct
transcription
initiation
elongation,
while
gene-activation
exploits
programmability
of
activate
gene
expression.
Recent
advances
in
CRISPRi
technology,
combination
other
technologies
(e.g.,
biosensing,
sequencing),
have
significantly
expanded
its
applications,
allowing
for
genome-wide
high-throughput
screening
(HTS)
identify
determinants
phenotypes.
These
strategies
been
applied
biomedicine,
industry,
basic
research.
This
review
explores
regulation
mechanisms,
offers
overview
workflow
CRISPR-based
screens,
highlights
superior
suitability
HTS
across
biomedical
industrial
applications.
Finally,
we
discuss
limitations
current
CRISPRi/a
envision
future
directions
CRISPR-mediated
research,
considering
potential
broader
application
diverse
fields.
Язык: Английский